CIK 0001395937 · Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320162505
- Phone
- 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $113,716
- in 1 filing, $114K under 10b5-1 plans
Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 25 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-15 | Huber Martin H. Jr. Director | Grant or award · Stock Options (Right to buy) | +35,000 | $19.36 | $678K | 35,000 |
| 2021-09-14 | Metzger Michael A President and COO | Option exercise | +44,349 | $7.20 | $319K | 62,008 |
| 2021-09-14 | Metzger Michael A President and COO | Sale | −44,349 | $19.15 | $849K | 17,659 |
| 2021-09-14 | Metzger Michael A President and COO | Option exercise · Stock Options (Right to buy) | −44,349 | 0 | ||
| 2021-09-13 | Metzger Michael A President and COO | Option exercise | +16,651 | $7.20 | $120K | 34,310 |
| 2021-09-13 | Metzger Michael A President and COO | Sale | −16,651 | $19.02 | $317K | 17,659 |
| 2021-09-13 | Metzger Michael A President and COO | Option exercise · Stock Options (Right to buy) | −16,651 | 0 | ||
| 2021-08-18 | Egros Fabrice Director | Option exercise | +15,635 | $7.88 | $123K | 31,635 |
| 2021-08-18 | Egros Fabrice Director | Sale | −15,635 | $15.75 | $246K | 16,000 |
| 2021-08-18 | Egros Fabrice Director | Option exercise · Stock Options (Right to buy) | −15,635 | 0 | ||
| 2021-05-18 | Egros Fabrice Director | Option exercise | +11,926 | $7.20 | $86K | 27,926 |
| 2021-05-18 | Egros Fabrice Director | Option exercise | +1,683 | $7.88 | $13K | 29,609 |
| 2021-05-18 | Egros Fabrice Director | Sale | −11,926 | $18.65 | $222K | 17,683 |
| 2021-05-18 | Egros Fabrice Director | Sale | −1,683 | $18.65 | $31K | 16,000 |
| 2021-05-18 | Egros Fabrice Director | Option exercise · Stock Options (Right to buy) | −1,683 | 0 | ||
| 2021-05-18 | Egros Fabrice Director | Option exercise · Stock Options (Right to buy) | −11,926 | 0 | ||
| 2021-04-26 | Meyers Michael L. SVP, Chief Medical Officer | Purchase | +500 | $15.46 | $8K | 15,666 |
| 2021-04-22 | Podlesak Dennis Director | Purchase | +13,967 | $14.11 | $197K | 43,300 |
| 2021-03-01 | Egros Fabrice Director | Option exercise | +10,167 | $6.35 | $65K | 26,167 |
| 2021-03-01 | Egros Fabrice Director | Option exercise | +74 | $7.20 | $533 | 26,241 |
Page 19 of 25 · 500 trades